{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:50:55Z","timestamp":1789084255063,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0437-2","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T13:36:42Z","timestamp":1488375402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Sadia Qamar","family":"Arain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah Naz","family":"Talpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem Aslam","family":"Channa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahbaz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Imran","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"437_CR1","doi-asserted-by":"publisher","unstructured":"Dorobantu C, Macovei A, Lazar C, Dwek RA, Zitzmann N and Branza-Nichita N. Cholesterol depletion of hepatoma cells impairs hepatitis b virus envelopment by altering the topology of the large envelope protein. J Virol. 2011;13373\u201383. doi: 10.1128\/JVI.05423-11 .","DOI":"10.1128\/JVI.05423-11"},{"key":"437_CR2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molimm.2012.06.014","volume":"201","author":"C Zhang","year":"2013","unstructured":"Zhang C, Gong L, Chen Y, Wang X, Zhua S, Ding L, Panga Y, Yina Y, Liua X, Zhu N. A human-derived protein SBP (HBsAg-binding protein) can bind to hepatitis B virus surface antigen (HBsAg) and enhance the immune response to hepatitis B virus (HBV) vaccine. Mol Immunol. 2013;201:60\u201371.","journal-title":"Mol Immunol"},{"key":"437_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2334","volume":"7","author":"MM Alam","year":"2007","unstructured":"Alam MM, Zaidi SZ, Malik SA, Shaukat S, Naeem A, Sharif S, Angez M, Butt JA. Molecular Epidemiology of Hepatitis B Virus genotypes in Pakistan. BMC Infect Dis. 2007;7:115. doi: 10.1186\/1471-2334 .","journal-title":"BMC Infect Dis"},{"key":"437_CR4","first-page":"484","volume":"22","author":"A Abbasi","year":"2012","unstructured":"Abbasi A, Bhutto AR, Butt N, Lal K, Munir SM. Serum Cholesterol: Could it be a Sixth Parameter of Child-Pugh Scoring System in Cirrhotics Due to Viral Hepatitis. J Coll Physicians Surg Pak. 2012;22:484\u20137.","journal-title":"J Coll Physicians Surg Pak"},{"key":"437_CR5","first-page":"70","volume":"3","author":"SK Mandal","year":"2012","unstructured":"Mandal SK, Sil K, Chatterjee S, Ganguly J, Chatterjee K, Sarkar P, Hazara S, Sardar D. A study on lipid profiles in chronic liver diseases. Nat J Med Res. 2012;3:70\u20132.","journal-title":"Nat J Med Res"},{"issue":"6","key":"437_CR6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000102155","volume":"1","author":"M Irshad","year":"2007","unstructured":"Irshad M, Dube R, Joshi YK. Impact of viral hepatitis on apo- and lipoprotein status in blood. Med Princ Pract. 2007;1(6):310\u20134.","journal-title":"Med Princ Pract"},{"key":"437_CR7","first-page":"509","volume":"51","author":"CC Vere","year":"2010","unstructured":"Vere CC, Neagoe D, Streba CT, Prejbeanu I, Ianosi G, Comanescu V, Pirici D. Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology. Romanian J Morphol Embryol. 2010;51:509\u201314.","journal-title":"Romanian J Morphol Embryol"},{"key":"437_CR8","first-page":"286","volume":"103","author":"TC Su","year":"2004","unstructured":"Su TC, Lee YT, Cheng TJ, Chien HP, Wang JD. Chronic hepatitis B virus infection and dyslipidemia. J Formos Med Assoc (Taiwan yi zhi). 2004;103:286\u201391.","journal-title":"J Formos Med Assoc (Taiwan yi zhi)"},{"key":"437_CR9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860\u20137.","journal-title":"Nature"},{"key":"437_CR10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.108.123885","volume":"53","author":"SG Anderson","year":"2009","unstructured":"Anderson SG, Sanders TA, Cruickshank JK. Plasma fatty acid composition as a predictor of arterial stiffness and mortality. Hypertension. 2009;53:839\u201345.","journal-title":"Hypertension"},{"key":"437_CR11","first-page":"691","volume":"139","author":"BM Arendt","year":"2009","unstructured":"Arendt BM, Mohammed SS, Aghdasasi E, Prayitno NR, Ma DWL, Nguyen A, Guindi M, Sherman M, Heathcote EJ, Allard JP. Hepatic fatty acid compission differs between chronic hepatitis C patients with and steatosis. J Am Soc Nutr. 2009;139:691\u20135.","journal-title":"J Am Soc Nutr"},{"key":"437_CR12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","volume":"53","author":"RH Unger","year":"2002","unstructured":"Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319\u201336.","journal-title":"Annu Rev Med"},{"key":"437_CR13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.physiol.65.092101.142622","volume":"65","author":"RH Unger","year":"2003","unstructured":"Unger RH. The physiology of cellular liporegulation. Annu Rev Physiol. 2003;65:333\u201347.","journal-title":"Annu Rev Physiol"},{"key":"437_CR14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1388-1981(02)00342-6","volume":"1585","author":"RH Unger","year":"2002","unstructured":"Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta. 2002;1585:202\u201312.","journal-title":"Biochim Biophys Acta"},{"key":"437_CR15","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1023\/A:1012338828418","volume":"46","author":"V Nehra","year":"2001","unstructured":"Nehra V, Angulo P, Buchman A, Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci. 2001;46:2347\u201352.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"437_CR16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2036.2008.03896.x","volume":"29","author":"VW Wong","year":"2009","unstructured":"Wong VW, Wong GL, Tsang SW, Hui AY, Chan AW, Choi PC, Chim AM, Chu S, Chan FK, Sung JJ, Chan HL. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther. 2009;29(4):387\u201396.","journal-title":"Aliment Pharmacol Ther"},{"key":"437_CR17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3748\/wjg.v16.i5.603","volume":"16","author":"AA Mastoi","year":"2010","unstructured":"Mastoi AA, Devrajani BR, Shah SZA, Rohopoto Q, Memon SA, Bloch M, Qureshi GA, Sami W. Metabolic investigations in patients with hepatitis B and C. World J Gastroenterol. 2010;16:603\u20137.","journal-title":"World J Gastroenterol"},{"key":"437_CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.9734\/IJBCRR\/2015\/14989","volume":"6","author":"SQ Arain","year":"2015","unstructured":"Arain SQ, Talpur FN, Channa NA. Clinical evaluation and serum lipid profile between individuals with acute hepatitis C. Int J Biochem Res Rev. 2015;6:37\u201345.","journal-title":"Int J Biochem Res Rev"},{"issue":"1","key":"437_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-11-1","volume":"11","author":"F Khan","year":"2011","unstructured":"Khan F, Akbar H, Idrees M, Khan H, Shahzad K, Kayani MA. The prevalence of HBV infection in the cohort of IDPs of war against terrorism in Malakand Division of Northern Pakistan. BMC Infect Dis. 2011;11(1):1.","journal-title":"BMC Infect Dis"},{"key":"437_CR20","first-page":"107","volume":"53","author":"NZ Janjua","year":"2003","unstructured":"Janjua NZ. Injection practices and sharp waste disposal by general practitioners of Murree, Pakistan. J Pak Med Assoc. 2003;53:107\u201311.","journal-title":"J Pak Med Assoc"},{"key":"437_CR21","volume-title":"Standards and guidelines for blood transfusion services","author":"BM Kazi","year":"1999","unstructured":"Kazi BM. Standards and guidelines for blood transfusion services. Islamabad: World Health Organization\/National Institute of Health, Federal Health Ministry, Government of Pakistan; 1999."},{"key":"437_CR22","first-page":"81","volume":"20","author":"M Rahman","year":"2004","unstructured":"Rahman M, Jawaid SA. Need for national blood policy to ensure safe blood transfusion. Pak J Med Sci. 2004;20:81\u20134.","journal-title":"Pak J Med Sci"},{"key":"437_CR23","first-page":"S25","volume":"56","author":"S Luby","year":"2006","unstructured":"Luby S, Khanani R, Zia M, Vellani Z, Ali M, Qureshi AH. Evaluation of blood bank practices in Karachi, Pakistan, and thegovernment\u2019s response. J Pak Med Assoc. 2006;56:S25\u201330.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"437_CR24","first-page":"79","volume":"22","author":"N Mahboobi","year":"2013","unstructured":"Mahboobi N, Porter SR, Karayiannis P, Alavian SM. Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature. J Gastrointestin Liver Dis. 2013;22(1):79\u201386.","journal-title":"J Gastrointestin Liver Dis"},{"key":"437_CR25","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/jnci\/djh334","volume":"96","author":"SH Jee","year":"2004","unstructured":"Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette Smoking, Alcohol Drinking, Hepatitis B, and Risk for Hepatocellular Carcinoma in Korea. J Natl Cancer Inst. 2004;96:1851\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"437_CR26","first-page":"154","volume":"25","author":"ME Staretz","year":"1997","unstructured":"Staretz ME, Murphy SE, Patten CJ, et al. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N\u2019-nitrosonornicotine in human hepatic microsomes. Drug Metab Dispos. 1997;25:154\u201362.","journal-title":"Drug Metab Dispos"},{"key":"437_CR27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.11342","volume":"107","author":"ZM Chen","year":"2003","unstructured":"Chen ZM, Liu BQ, Boreham J, et al. Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer. 2003;107:106\u201312.","journal-title":"Int J Cancer"},{"issue":"5","key":"437_CR28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/1055-9965.EPI-09-1297","volume":"19","author":"SC Chuang","year":"2010","unstructured":"Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1261\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"437_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2891-12-67","volume":"12","author":"K Shafique","year":"2013","unstructured":"Shafique K, Zafar M, Ahmed Z, Khan NA, Mughal MA, Imtiaz F. Areca nut chewing and metabolic syndrome: evidence of a harmful relationship. J Nutr. 2013;12(1):1.","journal-title":"J Nutr"},{"issue":"5","key":"437_CR30","first-page":"1829","volume":"28","author":"F Sajid","year":"2015","unstructured":"Sajid F, Bano S. Effects of smokeless dipping tobacco (Naswar) consumption on antioxidant enzymes and lipid profile in its users. Pak J Pharm Sci. 2015;28(5):1829\u201333.","journal-title":"Pak J Pharm Sci"},{"key":"437_CR31","doi-asserted-by":"crossref","unstructured":"Ahmed QR, Gupta N, Goyal S, Ansari SJ. Comparative study on lipid profile in tobacco chewers and nontobacco chewers. Natl J Physiol Pharm Pharmacol. 2015;5(2):142\u20134.","DOI":"10.5455\/njppp.2015.5.201120141"},{"key":"437_CR32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","volume":"124","author":"AJ Sanyal","year":"2003","unstructured":"Sanyal AJ, Genning C, Reddy KR, et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology. 2003;124:634\u201341.","journal-title":"Gastroenterology"},{"key":"437_CR33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","volume":"40","author":"DM Heuman","year":"2004","unstructured":"Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802\u201310.","journal-title":"Hepatology"},{"key":"437_CR34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"Kamath PS, Kim WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797\u2013805.","journal-title":"Hepatology"},{"key":"437_CR35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.metabol.2012.07.024","volume":"62","author":"J Hoover-Plow","year":"2013","unstructured":"Hoover-Plow J, Huang M. Lipoprotein (a) metabolism: Potential sites for therapeutic targets. Metabolism. 2013;62:479\u201391.","journal-title":"Metabolism"},{"key":"437_CR36","first-page":"285","volume":"10","author":"MR Ghadir","year":"2010","unstructured":"Ghadir MR, Riahin AA, Havaspour A, Nooranipour M, Habibinejad AA. The Relationship between Lipid Profile and Severity of Liver Damage in Cirrhotic Patients. Hepat Mon. 2010;10:285\u20138.","journal-title":"Hepat Mon"},{"key":"437_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heart.87.1.9","volume":"87","author":"S Moller","year":"2002","unstructured":"Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002;87:9\u201315.","journal-title":"Heart"},{"issue":"1","key":"437_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2459\/JCM.0000000000000149","volume":"16","author":"MM Ciccone","year":"2015","unstructured":"Ciccone MM, Principi M, Ierardi E, Di Leo A, Ricci G, Carbonara S, Gesualdo M, Devito F, Zito A, Cortese F, Scicchitano P. Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? J Cardiovasc Med. 2015;16(1):11\u201321.","journal-title":"J Cardiovasc Med"},{"key":"437_CR39","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.1152\/ajpendo.00507.2009","volume":"298","author":"AT Sage","year":"2010","unstructured":"Sage AT. Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells. Am J Physiol Endocrinol Metab. 2010;298:E499\u2013511.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"437_CR40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3164\/jcbn.12-79","volume":"53","author":"DR Medi","year":"2013","unstructured":"Medi DR, Taki M, Vucic V, Kandi D, Kosti N, Glibeti M. Abnormalities in the serum phospholipids fatty acid profile in patients with alcoholic liver cirrhosis\u2013a pilot study. J Clin Biochem Nutr. 2013;53:49\u201354.","journal-title":"J Clin Biochem Nutr"},{"key":"437_CR41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/hep.510280401","volume":"28","author":"E Mezey","year":"1988","unstructured":"Mezey E. Dietary fat and alcoholic liver disease. Hepatology. 1988;28:901\u20135.","journal-title":"Hepatology"},{"key":"437_CR42","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI5584","volume":"104","author":"EA Meagher","year":"1999","unstructured":"Meagher EA, Barry OP, Burke A. Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest. 1999;104:805\u201313.","journal-title":"J Clin Invest"},{"key":"437_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-2944(82)90066-7","volume":"28","author":"D Alvaro","year":"1982","unstructured":"Alvaro D, Angelico M, Attili AF, De Santis A, Pi\u00e9che U, Capocaccia L. Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis. Biochem Med. 1982;28:157\u201364.","journal-title":"Biochem Med"},{"key":"437_CR44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1172\/JCI116981","volume":"93","author":"MT Nakamura","year":"1994","unstructured":"Nakamura MT, Tang AB, Villanueva J, Halsted CH, Phinney SD. Selective reduction of \u03946 and \u03945 desaturase activities but not \u03949 desaturase in micropigs chronically fed ethanol. J Clin Invest. 1994;93:450\u20134.","journal-title":"J Clin Invest"},{"key":"437_CR45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000177992","volume":"41","author":"T Bamberg","year":"1997","unstructured":"Bamberg T, Pelletier X, Blain H, Jeandel C, Debry G. Effects of malnutrition and atherosclerosis on the fatty acid composition of plasma phospholipids in the elderly. Ann Nutr Metab. 1997;41:166\u201372.","journal-title":"Ann Nutr Metab"},{"key":"437_CR46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4684-3276-3_8","volume":"83","author":"RR Brenner","year":"1977","unstructured":"Brenner RR. Regulatory function of \u03946 desaturate\u2014key enzyme of polyunsaturated fatty acid synthesis. Adv Exp Med Biol. 1977;83:85\u2013101.","journal-title":"Adv Exp Med Biol"},{"key":"437_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.plefa.2004.03.019","volume":"71","author":"EN Smit","year":"2004","unstructured":"Smit EN, Muskiet FA, Boersma ER. The possible role of essential fatty acids in the pathophysiology of malnutrition: a review. Prostaglandins Leukot Essent Fatty Acids. 2004;71:241\u201350.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"437_CR48","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46:1081\u201390.","journal-title":"Hepatology"},{"issue":"117","key":"437_CR49","first-page":"1","volume":"14","author":"SQ Arain","year":"2015","unstructured":"Arain SQ, Talpur FA, Channa NA. A comparative study of serum lipid contents in pre and post IFN-alpha treated acute hepatitis C patients. J Lipids Health Dis. 2015;14(117):1\u20139.","journal-title":"J Lipids Health Dis"},{"key":"437_CR50","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.22183","volume":"47","author":"Z Li","year":"2008","unstructured":"Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomal mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology. 2008;47:1495\u2013503.","journal-title":"Hepatology"},{"key":"437_CR51","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem. 2006;281:12093\u2013101.","journal-title":"J Biol Chem"},{"key":"437_CR52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1744-313X.2011.01012.x","volume":"38","author":"W Cheg","year":"2011","unstructured":"Cheg W, Song C, Anjum KM. Coenzyme Q plays opposing roles on bacteria\/fungi and viruses in Drosophila innate immunity. Int J Immunogenet. 2011;38:331\u20137.","journal-title":"Int J Immunogenet"},{"key":"437_CR53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","volume":"21","author":"AP Simopoulos","year":"2002","unstructured":"Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495\u2013505.","journal-title":"J Am Coll Nutr"},{"key":"437_CR54","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.2174\/138161209789909746","volume":"15","author":"C Ruggiero","year":"2009","unstructured":"Ruggiero C, Lattanzio F, Lauretani F, Gasperini B, Andres-Lacueva C, Cherubini A. Omega-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis. Curr Pharm Des. 2009;15:4135\u201348.","journal-title":"Curr Pharm Des"},{"key":"437_CR55","doi-asserted-by":"crossref","first-page":"395","DOI":"10.7555\/JBR.26.20120058","volume":"26","author":"Z Wu","year":"2012","unstructured":"Wu Z, Qin J, Pu L. Omega-3 fatty acid improves the clinical outcome of hepatectomized patients with hepatitis B virus (HBV)-associated hepatocellular carcinoma. J Biomed Res. 2012;26:395\u20139.","journal-title":"J Biomed Res"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T11:39:57Z","timestamp":1498390797000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0437-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]},"article-number":"51"}}